Japan lab unable to replicate 'stem cell' findings

Image
AFP Tokyo
Last Updated : Aug 27 2014 | 2:30 PM IST
Researchers in Japan today said they have been unable to replicate experiments that were hailed earlier this year as a "game-changer" in the quest to grow transplant tissue, amid claims evidence was faked.
In a scandal that rocked Japan's scientific establishment, Riken -- the research institute that sponsored the study -- launched an independent experiment in April to verify research published by scientist Haruko Obokata and her colleagues earlier this year.
But the failure to replicate the experiment casts further doubt on the existence of stem cell-like cells, what the researchers called Stimulus-Triggered Acquisition of Pluripotency (STAP) cells.
"Researchers have conducted 22 experiments thus far, but we could not confirm the emergence of cells in the conditions described in (Obokata's) papers," Riken said in an interim report issued today.
Obokata since July has been trying in tandem with independent teams to reproduce her own results.
The researchers will continue their experiments under more diverse conditions while also considering data obtained by Obokata herself, Shinichi Aizawa, a special adviser at Riken, told a lengthy press conference.
Obokata was feted after unveiling findings that appeared to show a straightforward way to re-programme adult cells to become stem cells -- precursors that are capable of developing into any other cell in the human body.
Identifying a readily manufacturable supply of stem cells could one day help meet a need for transplant tissues, or even whole organs, meaning that any advance in the field is met with excitement in the scientific community.
But suspicions began to emerge in the weeks and months after the research was published, building into one of the biggest controversies in scientific publishing for a decade.
Leading science journal Nature withdrew the flawed stem-cell study after Obokata agreed in June to retract the papers.
Nature said it would tighten procedures to vet future studies submitted for publication.
It said the decision was taken after mistakes were discovered in some data published in two papers, photograph captions were found to be misleading, and the work itself could not be repeated by other scientists.
Earlier this month Obokata's co-author, stemcell scientist Yoshiki Sasai, hanged himself, further shaking Japan's scientific establishment.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 27 2014 | 2:30 PM IST

Next Story